We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$445M
AUM Growth
+$6.22M
(+1.4%)
Cap. Flow
+$4.93M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
17.39%
Holding
285
New
23
Increased
106
Reduced
62
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$2.81M |
| 2 |
RTX Corp
RTX
|
+$2.68M |
| 3 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$1.79M |
| 4 |
Parker-Hannifin
PH
|
+$1.6M |
| 5 |
KLA
KLAC
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KS
KapStone Paper and Pack Corp.
KS
|
+$4.63M |
| 2 |
Altria Group
MO
|
+$2.29M |
| 3 |
Procter & Gamble
PG
|
+$2.11M |
| 4 |
Philip Morris
PM
|
+$1.94M |
| 5 |
MON
Monsanto Co
MON
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.84% |
| 2 | Healthcare | 15.87% |
| 3 | Technology | 15.47% |
| 4 | Materials | 7.53% |
| 5 | Financials | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Aurinia Pharmaceuticals
AUPH
$1.97B
| $276K | 0.06% |
+48,994
| New | +$273K |
|
177
Integra LifeSciences
IART
$1.54B
| $258K | 0.06% |
4,000
| – | – |
|
|
CLLS
178
Cellectis
CLLS
$286M
| $252K | 0.06% |
+8,908
| New | +$265K |
|
179
Microsoft
MSFT
$2.84T
| $244K | 0.05% |
2,477
-2,540
| -51% | -$246K |
|
180
FTI Consulting
FCN
$4.82B
| $232K | 0.05% |
+3,830
| New | +$222K |
|
181
Alibaba
BABA
$269B
| $223K | 0.05% |
1,203
| – | – |
|
182
Manulife Financial
MFC
$72.6B
| $207K | 0.05% |
11,542
| – | – |
|
183
W.P. Carey
WPC
$17.1B
| $206K | 0.05% |
3,165
-5,616
| -64% | -$356K |
|
184
Extra Space Storage
EXR
$31.2B
| $200K | 0.04% |
+2,000
| New | +$186K |
|
|
NITE
185
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $195K | 0.04% |
+12,181
| New | +$174K |
|
186
Carlyle Secured Lending
CGBD
$698M
| $172K | 0.04% |
+10,112
| New | +$180K |
|
|
AFMD
187
DELISTED
Affimed
AFMD
| $100K | 0.02% |
+6,069
| New | +$128K |
|
188
SiriusXM
SIRI
$10B
| $68K | 0.02% |
+1,000
| New | +$67.5K |
|
189
Acadia Pharmaceuticals
ACAD
$4.25B
| – | – |
-13,946
| Closed | -$313K |
|
190
Clorox
CLX
$11.6B
| – | – |
-6,407
| Closed | -$853K |
|
191
ConocoPhillips
COP
$147B
| – | – |
-4,498
| Closed | -$267K |
|
192
Chevron
CVX
$388B
| – | – |
-2,328
| Closed | -$265K |
|
193
Quaker Houghton
KWR
$2.63B
| – | – |
-2,200
| Closed | -$326K |
|
|
194
Altria Group
MO
$122B
| – | – |
-36,673
| Closed | -$2.29M |
|
|
MRSN
195
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-710
| Closed | -$280K |
|
|
196
Procter & Gamble
PG
$343B
| – | – |
-26,644
| Closed | -$2.11M |
|
|
197
Philip Morris
PM
$301B
| – | – |
-19,559
| Closed | -$1.94M |
|
|
PPL
198
PPL Corp
PPL
$27.3B
| – | – |
-6,954
| Closed | -$197K |
|
|
SYBX
199
DELISTED
Synlogic
SYBX
| – | – |
-1,770
| Closed | -$249K |
|
200
Theriva Biologics
TOVX
$10.2M
| – | – |
-7
| Closed | -$19K |
|
Similar funds
VFG
KCP
AR
CICI
UAG
PS
BC
RPAM
Stanley-Laman Group's Q2 2018 Portfolio in Review
As of Q2 2018, Stanley-Laman Group held 285 positions worth $445M, up 1.4% from $439M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Stanley-Laman Group's Q2 2018 filing shows 23 new, 106 increased, 62 reduced and 22 closed positions. Its largest new stake was Honeywell: 21,094 shares worth $2.75M. The largest sale was KapStone Paper and Pack Corp., an estimated $4.63M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- Stanley-Laman Group's largest Q2 2018 buy was Honeywell: 21,094 shares worth $2.75M.
- Stanley-Laman Group added most to Neurocrine Biosciences in Q2 2018, an estimated $960K increase.
- Stanley-Laman Group's biggest Q2 2018 reduction was Qualys, cutting an estimated $1.16M.
- Stanley-Laman Group fully exited KapStone Paper and Pack Corp. in Q2 2018, selling an estimated $4.63M.
- Stanley-Laman Group's ten largest holdings make up 17% of its $445M portfolio in Q2 2018.
- Stanley-Laman Group opened 23 new positions and closed 22 in Q2 2018.
- Stanley-Laman Group's portfolio value rose 1.4% quarter-over-quarter to $445M.
Based on Stanley-Laman Group's 13F filing for Q2 2018, filed 9 Aug 2018.